oajx Couples Who Do This Together Are Happier

MorrissZet

Pkgi Louis Gossett Jr. on the Original Roots and the Black History That s Yet to Be Filmed
The power of social media virality and Gen Zs merciless wit have transmuted a boring Chinese chemical product into an overnight internet sensation stanley flasche .     If youve never heard of Donghua Jinlong, well, that makes sense. After all, its a nondescript company based in Shijiazhuang, China that sells a chemical compound most people have never heard of. Specifically, the company sells various types of industrial-grade glycine, which is a food additive that, in moderation, is alleged to have some positive health benefits. Anyway, despite its poor prospects as a brand, Donghua Jinlong did one thing right recently, which was to try its hand at viral marketing. In October of 2023, the company began stanley travel mug  releasing TikTok videos advertising its products. Unfortunately  or, maybe, fortunately  for Donghua Jinlong, the company is pretty terrible at making TikTok videos. Truly, the companys videos are a study in unintentional hilarity. A robotic voice sells viewers on the benefits of industrial-grade food additives with all the unironic earnestness of a door-to-door religious zealot. Meanwhile, when it comes to video production, little effort is spared on the traditional tropes of advertising鈥攍ike, say, a story or characters or a catchy jingle. Instead, the viewer is treated to endless stock imagery of the companys factory interiors and exteriors, as well as video of various test tubes that presumably hol stanley cup d some of the companys scrumptious glycine. Naturally, young people were not going to let this  Evwq Zoom Contradicts Its Own Policy About Training AI on Your Data
DNA helicesLawrence Lawrymdash;Getty Images/Science Photo LibraryBy Nathalia HoltFebruary 24, 2014 5:45 AM ESTThere is grandeur in the small science emerging from a select group of the worldrsquo  laboratories. This small  stanley cup science is about to change how we tackle our most troublesome diseases.Gene therapy. Immunotherapy. Nanomedicine. This is what the next few decades of medicine will look like. But it isnrsquo;t coming from big pharma. Itrsquo  coming from the little guys. Small pharmaceutical and biotechnology c stanley canada o stanley cups mpanies, once overlooked for both their risky science and questionable market share, are revolutionizing how the industry pursues new therapies. This shift in science comes as big pharma is falling stagnant. Last year, the bulk of profits made by big pharma came from drugs approved prior to 2001. If we look at the percent of big pharmarsquo  profits from drugs created within the last five years, the picture is grim. On average, new therapies make up only 8.3% of their profits. The patents are running out and big pharmarsquo  science is sluggish. Now the underdogs of the industry, small pharma and biotech, are poised to take on what were once considered incurable diseases. Why are little companies succeeding while big ones are sliding  It comes down to risk.This risk starts with the pursuit of great science. Edward Lanphier couldnrsquo;t get anyone at his company interested in a new technology capable of precisely cutting DNA so he decided to form his own.